When Your Genome Costs Less Than Your iPhone: The Beautiful, Terrifying Future of DNA Sequencing
By Jo Best,
Tech Republic
| 06. 05. 2015
Untitled Document
Dan Lane has always had a keen interest in the next big thing. He owned an early set of Google Glass, got his first RFID implant 10 years ago. Working in technology, he'd always been curious to try out the latest piece of kit or new service. So when 23andMe, a company that offers customers insight into their own DNA, opened up in the UK, he decided he'd give that a try too.
23andMe works like this: you get sent a small tube in the post, you spit into it, and send it away to be analysed. That little sample of saliva may not seem like much, but it holds a few of your cheek cells, each of which contains your entire genome—all the DNA that makes you, you. A few weeks later after the tube arrives, 23andMe sends you back a personalised interpretation of your DNA.
Services like 23andMe can unpick your genome to discover information on a range of traits: how you react to certain drugs; your risk of developing particular diseases; what characteristics you might...
Related Articles
By David Jensen, California Stem Cell Report | 02.10.2026
Touchy issues involving accusations that California’s $12 billion gene and stem cell research agency is pushing aside “good science” in favor of new priorities and preferences will be aired again in late March at a public meeting in Sacramento.
The...
By Lauren Hammer Breslow and Vanessa Smith, Bill of Health | 01.28.2026
On Jan. 24, 2026, the New York Times reported that DNA sequences contributed by children and families to support a federal effort to understand adolescent brain development were later co-opted by other researchers and used to publish “race science”...
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...